Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent.

Slides:



Advertisements
Similar presentations
Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2 by Barbara Margosio, Daniela Marchetti, Veronica Vergani, Raffaella Giavazzi,
Advertisements

An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels by Carina J. M. van Schooten,
PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,
Shielding the front-strand β3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibα by Arnaud Bonnefoy, Hiroshi Yamamoto,
by Kesheng Dai, Richard Bodnar, Michael C. Berndt, and Xiaoping Du
by Hong Yin, Aleksandra Stojanovic, Nissim Hay, and Xiaoping Du
Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3 by Cindy L. Yap, Karen.
CD44-Mediated Adhesiveness of Human Hematopoietic Progenitors to Hyaluronan Is Modulated by Cytokines by Stéphane Legras, Jean-Pierre Lévesque, Rachida.
by Xiuli An, Emilie Gauthier, Xihui Zhang, Xinhua Guo, David J
Missense Mutations of the Glycoprotein (GP) Ibβ Gene Impairing the GPIb α/β Disulfide Linkage in a Family With Giant Platelet Disorder by Shinji Kunishima,
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation by Ton Lisman, Jelle Adelmeijer,
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow by.
The adapter protein CrkL associates with CD34
by Leila M. Lopes Bezerra, and Scott G. Filler
Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II by Domenick J. Falcone, Wolfgang Borth,
by Nayna Mistry, Susan L. Cranmer, Yuping Yuan, Pierre Mangin, Sacha M
Identification of the receptor scavenging hemopexin-heme complexes
Annexin A2 tetramer activates human and murine macrophages through TLR4 by Jennifer F. A. Swisher, Nicholas Burton, Silvia M. Bacot, Stefanie N. Vogel,
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding by Ana Kasirer-Friede, Jian Kang, Bryan.
Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1 by Nijing Sheng,
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating.
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
by Jan Schulte am Esch, Miguel A. Cruz, Jonathan B
by Rong L. He, Jian Zhou, Crystal Z
Α-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation.
Conjugation of Blocked Ricin to an Anti-CD19 Monoclonal Antibody Increases Antibody-Induced Cell Calcium Mobilization and CD19 Internalization by Anne-Christine.
An event of shear importance
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald.
by Jörg Hartleib, Nicola Köhler, Richard B. Dickinson, Gursharan S
Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets by Brian Boylan, Cunji Gao, Vipul.
A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor.
A role for the thiol isomerase protein ERP5 in platelet function
Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells by Hitoshi Hasegawa, Tetsuhiko.
by Harish Shankaran, Paschalis Alexandridis, and Sriram Neelamegham
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress by Armin J. Reininger, Harry F. G. Heijnen,
Vitronectin Concentrates Proteolytic Activity on the Cell Surface and Extracellular Matrix by Trapping Soluble Urokinase Receptor-Urokinase Complexes by.
Molecular Mechanisms of Monocyte Adhesion to Interleukin-1β–Stimulated Endothelial Cells Under Physiologic Flow Conditions by Sharad Kukreti, Konstantinos.
Differential Effect of E-Selectin Antibodies on Neutrophil Rolling and Recruitment to Inflammatory Sites by Carroll L. Ramos, Eric J. Kunkel, Michael B.
by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia by Lubica Rauova, Mortimer Poncz, Steven E.
Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection by Katherine K. Wynn, Zara.
VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of shear flow by P. Sriramarao, Richard G. DiScipio, Ronald R.
C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald.
Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils.
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity by Gary E. Gilbert, Valerie A. Novakovic,
Brian Savage, Enrique Saldívar, Zaverio M Ruggeri  Cell 
Platelet-Derived Interleukin-1 Induces Cytokine Production, but not Proliferation of Human Vascular Smooth Muscle Cells by Harald Loppnow, Rosita Bil,
The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18)‏ by Ludwig T. Weckbach,
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor by Anne F. Riddell,
Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition.
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations by Bénédicte Dumont, Dominique Lasne, Chantal Rothschild,
Volume 112, Issue 1, Pages (January 2003)
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.
Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation by Frederic Lagarrigue, Alexandre R. Gingras,
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow  Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri 
Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects by Constance C. F. M. J. Baaten, Frauke Swieringa, Tomasz Misztal,
by Changjie Zhang, Anju Kelkar, and Sriram Neelamegham
Volume 124, Issue 7, Pages (June 2003)
Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib by Alexander P. Bye, Amanda J. Unsworth,
Serologic characterization of anti-protamine/heparin and anti-PF4/heparin antibodies by Grace M. Lee, Manali Joglekar, Maragatha Kuchibhatla, Sanjay Khandelwal,
The von Willebrand Factor protein showing various functional domains that have been mapped to regions of the cDNA. The von Willebrand Factor protein showing.
Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura by Liang Zheng, Yingying.
Fibrinogen fragments and platelet dysfunction in uremia
Src kinases mediate TSP-1 inhibition of AC and PKA activity.
by John C. Kermode, Qi Zheng, and Elizabeth P. Milner
Volume 8, Issue 2, Pages (February 1998)
by Babs O. Fabriek, Robin van Bruggen, Dong Mei Deng, Antoon J. M
Presentation transcript:

Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions by Jing-Fei Dong, Michael C. Berndt, Alicia Schade, Larry V. McIntire, Robert K. Andrews, and José A. López Blood Volume 97(1):162-168 January 1, 2001 ©2001 by American Society of Hematology

Schema showing the location of the epitopes used in the current study Schema showing the location of the epitopes used in the current study.(A) Monoclonal anti-vWF antibodies. Schema showing the location of the epitopes used in the current study.(A) Monoclonal anti-vWF antibodies. (B) Anti-GPIbα antibodies. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of anti-vWF and anti-GP Ibα antibodies on vWF binding to platelets.(A) Effect of the anti-vWF monoclonal antibodies (10 μg/mL, final concentration) on specific binding of 125I-labeled vWF (1 μg/mL) to washed platelets (5 × 107) in the presence of eit... Effect of anti-vWF and anti-GP Ibα antibodies on vWF binding to platelets.(A) Effect of the anti-vWF monoclonal antibodies (10 μg/mL, final concentration) on specific binding of 125I-labeled vWF (1 μg/mL) to washed platelets (5 × 107) in the presence of either 1 mg/mL (final concentration) ristocetin (▪) or 2.5 μg/mL botrocetin (■).7 The labeled vWF was incubated with the cells for 30 minutes at 22°C, after pre-incubating the platelets with the antibody for 5 minutes. Maximum binding was measured in the absence of antibody, and nonspecific binding was determined in the absence of modulator, in parallel assays. Data are the mean of triplicate determinations (± SEM). (B) Effect of anti-GP Ibα monoclonal antibodies (10 μg/mL, final concentration) on specific binding of125I-labeled vWF to washed platelets in the presence of either ristocetin (▪) or botrocetin (■) using the same assay as described in the legend to panel A.9 10 Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of increasing concentrations of AN51 and AK2 on ristocetin- and botrocetin-dependent binding of vWF to platelets and on shear-dependent platelet aggregation. Effect of increasing concentrations of AN51 and AK2 on ristocetin- and botrocetin-dependent binding of vWF to platelets and on shear-dependent platelet aggregation. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of anti-GP Ibα monoclonal antibodies on the adhesion of GP Ib-IX–expressing CHO cells to vWF under flow.Mean velocities are shown for CHOαβIX cells rolling over a glass surface coated with 50 μg/mL vWF (this concentration saturates the vWF binding si... Effect of anti-GP Ibα monoclonal antibodies on the adhesion of GP Ib-IX–expressing CHO cells to vWF under flow.Mean velocities are shown for CHOαβIX cells rolling over a glass surface coated with 50 μg/mL vWF (this concentration saturates the vWF binding sites on the glass coverslip) after the application of a shear stress of 10 dynes/cm2. CHOβIX cells, lacking GP Ibα, did not adhere to the surface. Where indicated, CHOαβIX cells were pretreated with monoclonal antibody at 25 μg/mL for 15 minutes. This concentration was well above the saturating concentration for each of these antibodies. Results are the means of analysis of 300 to 700 cells from 3 to 5 experimental runs. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of anti-vWF monoclonal antibodies on binding of GP Ibα-expressing CHO cells to vWF under flow.The experiment was conducted as in Figure 4 except that the vWF-coated surfaces, rather than the cells, were pretreated with monoclonal antibodies (25 μg/mL... Effect of anti-vWF monoclonal antibodies on binding of GP Ibα-expressing CHO cells to vWF under flow.The experiment was conducted as in Figure 4 except that the vWF-coated surfaces, rather than the cells, were pretreated with monoclonal antibodies (25 μg/mL, 15 minutes). Results are the means of analysis of 300 to 700 cells from 3 to 5 experimental runs. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of anti-GP Ibα monoclonal antibodies on shear-induced platelet aggregation.Shear-induced aggregation in platelet-rich plasma was measured in the absence of antibodies or after pre-incubating the sample with 25 μg/mL antibody (a concentration that far... Effect of anti-GP Ibα monoclonal antibodies on shear-induced platelet aggregation.Shear-induced aggregation in platelet-rich plasma was measured in the absence of antibodies or after pre-incubating the sample with 25 μg/mL antibody (a concentration that far exceeds the saturating concentration for each antibody) for 5 minutes at ambient temperature before the application at 90 dynes/cm2 of shear stress in a cone-and-plate viscometer. Results are the means of 4 to 8 experiments performed using different donors. *P < .05; **P < .001. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Effect of anti-vWF monoclonal antibodies on shear-induced platelet aggregation.Shear-induced aggregation in platelet-rich plasma was measured in the absence of antibodies or after pre-incubating the sample with 25 μg/mL antibody (final concentration) for 5 ... Effect of anti-vWF monoclonal antibodies on shear-induced platelet aggregation.Shear-induced aggregation in platelet-rich plasma was measured in the absence of antibodies or after pre-incubating the sample with 25 μg/mL antibody (final concentration) for 5 minutes at ambient temperature before the application of shear at 40, 90, or 120 dynes/cm2. Results are the means of 4 to 8 experiments performed using different donors. *P < .05; **P < .001. Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology

Epitopes for anti-vWF monoclonal antibodies Epitopes for anti-vWF monoclonal antibodies.Structure of the vWF A1 domain based on the radiograph crystal coordinates39 with highlighted sequences representing epitopes for the anti-vWF antibodies 6G1 and CR2.7 The Cα locations of gain-of-function point mu... Epitopes for anti-vWF monoclonal antibodies.Structure of the vWF A1 domain based on the radiograph crystal coordinates39 with highlighted sequences representing epitopes for the anti-vWF antibodies 6G1 and CR2.7 The Cα locations of gain-of-function point mutations in type 2B von Willebrand disease are shown as van der Waal spheres.38The figure was generated using the Quanta package (MSI, San Diego, CA). Jing-Fei Dong et al. Blood 2001;97:162-168 ©2001 by American Society of Hematology